Population pharmacokinetics of vancomycin in premature Malaysian neonates: identification of predictors for dosing determination.
about
Clinical pharmacokinetics of vancomycin in the neonate: a reviewTowards Rational Dosing Algorithms for Vancomycin in Neonates and Infants Based on Population Pharmacokinetic Modeling.External Evaluation of Population Pharmacokinetic Models of Vancomycin in Neonates: The transferability of published models to different clinical settings.Clinical Utility and Safety of a Model-Based Patient-Tailored Dose of Vancomycin in Neonates.Pooled population pharmacokinetic model of imipenem in plasma and the lung epithelial lining fluidOptimizing drug development of anti-cancer drugs in children using modelling and simulation.Determination of vancomycin pharmacokinetics in neonates to develop practical initial dosing recommendations.Vancomycin: a review of population pharmacokinetic analyses.Current understanding of PTX3 protective activity on Aspergillus fumigatus infection.Population pharmacokinetic analysis during the first 2 years of life: an overview.How to use vancomycin optimally in neonates: remaining questions.Renal Function Descriptors in Neonates: Which Creatinine-Based Formula Best Describes Vancomycin Clearance?Pharmacometric Approaches to Personalize Use of Primarily Renally Eliminated Antibiotics in Preterm and Term Neonates.Assessment of initial vancomycin dosing in neonatesStructure-Based Prediction of Anti-infective Drug Concentrations in the Human Lung Epithelial Lining Fluid.Evaluation of Vancomycin Use in Late-Onset Neonatal Sepsis Using the Area Under the Concentration-Time Curve to the Minimum Inhibitory Concentration ≥400 Target.Evaluating renal function and age as predictors of amikacin clearance in neonates: model-based analysis and optimal dosing strategies.Semiphysiological versus empirical modelling of the population pharmacokinetics of free and total cefazolin during pregnancy.A population pharmacokinetic model for individualised dosage regimens of vancomycin in Chinese neonates and young infants.Evaluating the Relationship between Vancomycin Trough Concentration and 24-Hour Area under the Concentration-Time Curve in Neonates.Why standards are useful for predicting doses.
P2860
Q36104107-3F04EB6F-AC66-4DF8-AD77-B27DF329EB7CQ36571794-71971538-84EE-4441-BF56-387BA96EE635Q36729959-9BB83A51-61C2-42A0-BA8B-D7D5C4E2F93DQ36730100-8D6D1570-070D-4AEC-AD44-F97CEC6CE2DFQ36924714-B17E1BC7-BB7E-4955-B5EC-90952D06EE8DQ36987975-D207883A-C60E-4804-BEFA-704D2CBC2E3BQ37712974-AA0651ED-5C32-4F73-8BDF-4D43C66AD4BBQ37965578-2DA53ABD-8A20-4512-B9EC-60691897E6EAQ37981720-CEF3E000-3A23-40BE-9CE8-0CBE587B489EQ38062388-FD8FDAC9-0B14-4F11-BCA9-4E316F783D7DQ38569678-1A47110B-3D30-4091-A909-C21867E77657Q38594191-02AD0571-6AFF-4758-809F-CFC94E80F590Q38696468-452D0702-583D-4E28-949D-6397CA3DB118Q39110114-E9C2568A-85D9-4ED0-9A99-997CC89F9F96Q40252977-C6170A09-0A65-4941-A5E6-FD42D81F3616Q40327439-F1A7292E-20E4-4DBD-A686-93AAE6CF8BFFQ41827371-38604217-8A75-42E6-A253-EE8551918ED1Q41967888-370D3D98-E012-4EB9-95FF-6E0E2247FE9FQ47183620-37F21756-01E6-445A-A7FE-9B3FF93B5D60Q49874675-3784184D-CBF9-4214-97D2-AF059CFCEC56Q50457678-58693549-2CE1-4273-97CF-9E2A2AA82E5C
P2860
Population pharmacokinetics of vancomycin in premature Malaysian neonates: identification of predictors for dosing determination.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Population pharmacokinetics of ...... tors for dosing determination.
@en
type
label
Population pharmacokinetics of ...... tors for dosing determination.
@en
prefLabel
Population pharmacokinetics of ...... tors for dosing determination.
@en
P2093
P2860
P356
P1476
Population pharmacokinetics of ...... tors for dosing determination.
@en
P2093
Bruce G Charles
Chin-Theam Lim
Johan G C van Hasselt
Siow-Chin Heng
Toong-Chow Lee
Yoke-Lin Lo
P2860
P304
P356
10.1128/AAC.01370-09
P407
P577
2010-04-12T00:00:00Z